Saturday, October 3, 2026

GBP/EUR Went Down By Over 1% In The Last 10 Sessions

ViaNews Editorial Team

December 28, 2023

GBP/EUR Went Down By Over 1% In The Last 10 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.03% for the last 10 sessions. At 05:11 EST on Thursday, 28 December, GBP/EUR (GBPEUR) is $1.15.

GBP/EUR's yearly highs and lows, it's 3.224% up from its 52-week low and 2.345% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy analysis: dollar still under pressure - 26 December 2023. According to DailyForex on Tuesday, 26 December, "Recently, USD/JPY is stabilizing around the level of 142.40 at the time of writing the analysis and during the annual holiday week.", "As a result, the USD/JPY tumbled towards the support level of 140.95, the lowest for the pair in five months. "
  • Usd/jpy drops through 142.00 as US dollar sells off. According to FXStreet on Wednesday, 27 December, "The USD/JPY fell nine-tenths of a percent on Wednesday as the market leans into bets that the Federal Reserve (Fed) will get pushed into a faster pace of rate cuts in 2024, with some investors expecting rate cuts to begin as soon as next March.", "The USD/JPY has slipped through recent consolidation after a rejection from the 200-hour Simple Moving Average (SMA) near 142.70, tumbling through the 142.00 handle and testing fresh weekly lows near 141.60."
  • Usd/jpy faces pressure near 143.00 as fed’s rate cut bets soar. According to FXStreet on Wednesday, 27 December, "The USD/JPY pair delivered a pullback move after discovering moderate buying interest near 142.00. "
  • According to FXStreet on Tuesday, 26 December, "At the time of writing, the USD/JPY pair is trading around 142.32, down 0.08% on the day."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com